Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients

Diabetes Research and Clinical Practice

Volumn 82, Issue 2, 2008, Pages 203-208

  Turunc, Tuba ^a   Demiroglu, Y Ziya ^a   Aliskan, Hikmet ^a   Colakoglu, Sule ^a   Arslan, Hande ^a  

^a Department of Infectious Diseases and Clinical Microbiology ^*  (Turkey)

Author keywords

Atypic; Diabetes mellitus; Manifestations; Mucormycosis

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; CAROTID ARTERY; CAVERNOUS SINUS; CHRONIC KIDNEY FAILURE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; FATALITY; FEMALE; HUMAN; LABORATORY TEST; MALE; MUCORMYCOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOPLEGIA; ORBIT APEX SYNDROME; ORBIT CELLULITIS; ORBIT DISEASE; RETROSPECTIVE STUDY; STROKE;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; MUCORMYCOSIS; RETROSPECTIVE STUDIES;

EID: 54549104603     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.07.011     Document Type: Article

References (38)

1. Bodey G., Bueltmann B., Duguid W., Gibbs D., Hanak H., Hatchi M., et al. Fungal infections in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11 (1992) 99-109
2. Denning D.W., and Stevens D.A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev. Infect. Dis. 12 (1990) 1147-1201
3. Hagensee M.E., Bauwens J.E., Kjos B., and Bowden R.A. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center. 1984-1992. Clin Infect. Dis. 19 (1994) 402-408
4. Pfaffenbach B., Donhuijsen K., Pahnke J., Bug R., Adarnek R.J., Wegener M., et al. Systemische Pilzinfektionen bei hamatologischen Neoplasien, eine Autopsie-Studie an 1053 patienten. Med. Klin. 89 (1994) 299-304
5. Pagona L., Ricci P., Tonso A., Nasori A., Cudillo C., Montillo M., et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. Br. J. Haematol. 99 (1997) 331-336
6. Walsh T.J., and Groll A.H. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty first century. Transplant Infect. Dis. 1 (1999) 247-261
7. Leong K., Crowley B., White B., Crotty G.M., O'Brain D.S., Keone C., et al. Cutaneus mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation. Bone Marrow Transplant. 19 (1997) 513-515
8. Jantunen E., Kolho E., Ruutu P., Kauhile-Kahleola P., Viraloinen M., Juvonen E., et al. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogenic bone marrow transplantation. Bone Marrow Transplant. 18 1 (1996) 229-230
9. Fingeroth J.D., Roth R.S., and Talcott J.A. Zygomycosis due to Mucor circinelloides in a neutropenic patient receiving chemotherapy for acute myelogenous leukemia. Clin. Infect. Dis. 19 (1994) 135-137
10. Chmel H., and Grieco M.H. Cerebral mucormycosis and renal aspergillosis in heroin addicts without endocarditis. Am. J. Med. Sci. 266 3 (1973) 225-231
11. Weng De, Wilson W.H., and Little R. Successful medical treatment of isolated renal zygomycosis case report and review. Clin. Infect. Dis. 26 (1998) 601-605
12. Reinhardt F.J., Kaplan W., and Ajello L. Experimental cerebral zygomycosis in alloxan-diabetic rabbits. I. Relationship of temperature tolerance of selected Zygomycetes to pathogenicity. Infect. Immun. 2 (1970) 404
13. Eucker J., Sezer O., Graf B., and Possinger K. Mucormycosis. Mycoses 44 (2001) 253-260
14. Van Den Saffele J.K., and Boelaert J.R. Zygomycosis in HIV-positive patients: a review of the literature. Mycoses 39 (1996) 77-84
15. Sheldon W.H., and Bauer H. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J. Exp. Med. 110 (1959) 845-852
16. Waldorf A.R., Ruderman N., and Diamond R.D. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage dense against Rhizopus. J. Clin. Invest. 74 (1984) 150-160
17. Peterson K.L., Wang M., Canalis R.F., and Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 107 (1997) 855-862
18. Sugar A.M., and Mucormycosis. Clin. Infect. Dis. 14 (1992) 126-129
19. Chimelli L., and Mahler-Araujo M.B. Fungal infections. Brain Pathol. 7 (1997) 613-627
20. Van Cutsem J., and Boelaert J.R. Effects of deferoxamine feroxamine and iron on experimental mucormycosis. Kidney Int. 36 (1989) 1061-1068
21. Boelaert J.R., Van Cutsem J., Locht M., Schneider Y.S., and Crichton R.R. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int. 45 (1994) 667-671
22. Maertens J., Demuynck H., Verbeken E.K., Rachee P., Verhoev G., Vandenberghe P., et al. Mucormycosis in allogenic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant. 24 (1999) 307-312
23. Pizzo P.A. Management of fever in patients with cancer and treatment induced neutropenia. N. Engl. J. Med. 328 (1993) 1323-1332
24. Bodey G.P., Anaissie E., Gutterman J., and Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin. Infect. Dis. 17 (1993) 705-707
25. Roden M.M., Zaoutis T.E., Buchanan W.L., Knudsen T.A., Sarkisova T.A., Schaufele R.L., et al. Epidemiology and outcame of zygomycosis: a review of 929 reporeted cases. Clin. Infect. Dis. 41 (2005) 635-653
26. Oyesi{dotless}ku N.M., Schwarzmann S.W., and Alleyne Jr. C.H. Fungal infections in the brain. In: Osenbach R.K., and Zei{dotless}dman S.M. (Eds). Infections in Neurological Surgery (1999), Lippincott-Raven, Philadelphia pp. 123-139
27. Moll G., Rai{dotless}la F., Li{dotless}u G., and Conerly W. Rhinocerebral mucormycosis in IDDM. Diab. Care 17 (1994) 1348-1353
28. Lowe J.T., and Hudson W.R. Rhinocerebral phycomycosis and internal carotid artery thrombosis. Arch. Otolaryngol. 101 (1975) 100-103
29. Galeta S.L., Wulc A.E., Goldberg H.I., and Nichols C.W. Rhinocerebral mucormycosis: management and survival after carotid occlusion. Ann. Neurol. 28 (1990) 103-107
30. Mathur S.C., Friedman H.D., Kende A.I., Davis R.I., and Graziano S.L. Critic Mucor infection leading to massive cerebral infarction at initiation of antileukemic chemotherapy. Ann. Haematol. 78 (1999) 241-245
31. Anaissie E.J., and Shikkani A.H. Rhinocerebral mucormycosis with internal carotid occlusion: report of 2 cases and review of the literature. Laryngoscope 95 (1985) 1107-1113
32. O'Brien T.J., and McKelvie P. Rhinocerebral mucormycosis presenting as periorbitalcellulitis with blindness: report of 2 cases. Clin. Exp. Neurol. 31 (1994) 68-78
33. Thajeb P., Thajeb B., and Dai D. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy. Scand. J. Infect. Dis. 36 (2004) 643-648
34. Tedder M., Spratt J., Anstadtm M., Hedge S., and Tedder S. Pulmonary mucormycosis; results of medical and surgical theraphy. Ann. Thorac. Surg. 57 (1994) 1044-1050
35. Walsh T.J., Finberg R.W., Arndt C., Hiemenz J., Schwartz C., Bodensteiner D., et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N. Engl. J. Med. 340 (1999) 764-771
36. Ellis M., Spence D., Pauw B., Meunier F., Marinus A., Colette L., et al. An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. Clin. Infect. Dis. 27 (1998) 1406-1412
37. Leenders A.C., Daenen S., Jansen R., Hop W.C., Lowenberg B., Wijermans P.W., et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br. J. Haematol. 103 (1998) 205-212
38. Prentice H.G., Hann I.M., Herbrecht R., Aoun M., Kualay S., Catavshy D., et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br. J. Haematol. 98 (1997) 711-718